Skip to Main Content

Advertisement

Skip Nav Destination

First Edition

Research Article April 15 2024
Acalabrutinib, venetoclax and obinutuzumab in relapsed CLL: Final efficacy and ctDNA analysis of the CLL2-BAAG trial
Research Article April 15 2024
Reassessing the Chronic Lymphocytic Leukemia International Prognostic Index in the era of targeted therapies
Research Article April 15 2024
SOX11 expression is restricted to EBV-negative Burkitt lymphoma and associates with molecular genetic features
Research Article April 15 2024
Fitusiran reduces bleeding in Factor X-deficient mice
Review Article April 11 2024
What Clinicians Should Know About Surrogate Endpoints in Hematologic Malignancies
Research Article April 11 2024
Notch1 regulates hepatic thrombopoietin production
Research Article April 11 2024
GM-CSF receptor expression determines opposing innate memory phenotypes at different stages of myelopoiesis
Research Article April 10 2024
NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenome
Research Article April 10 2024
Variation in Mesenchymal KITL/SCF and IGF1 Expression at Middle Age Underlies Steady-State Hematopoietic Stem Cell Aging
Research Article April 8 2024
Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma
Research Article April 5 2024
Wiskott-Aldrich Syndrome: A study on 577 patients defining the genotype as a predictive biomarker for disease severity
Research Article April 5 2024
IL-18-secreting multi-antigen targeting CAR T-cells eliminate antigen-low myeloma in an immunocompetent mouse model
Research Article April 5 2024
Bone marrow niches for hematopoietic stem cells: Lifespan dynamics and adaptation to acute stress.
Research Article April 5 2024
Loss of stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AML
Research Article April 5 2024
Mortality, cardiac and cerebral damages reduction by IL-1 inhibition in a murine model of TTP
Research Article April 4 2024
Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia
Research Article April 1 2024
Axicabtagene ciloleucel versus standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume
Research Article April 1 2024
B-cell-directed CAR-T cell therapy activates CD8+ cytotoxic CARneg bystander T-cells in non-human primates and patients
Review Article March 29 2024
Unraveling MCL biology to understand resistance and identify vulnerabilities
Research Article March 29 2024
Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma
Research Article March 29 2024
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL
Letter March 25 2024
Excess of circulating apo-transferrin enhances dietary iron absorption
Research Article March 22 2024
The IL-7R antagonist Lusvertikimab reduces leukemic burden in xenograft-ALL via antibody-dependent cellular phagocytosis
Research Article March 22 2024
Genomic imbalances analysis provides new insight into prognostic factors in adult and pediatric T-ALL
Research Article March 22 2024
An Oral Carbon Monoxide-Releasing Molecule Protects against Acute Hyper-hemolysis in Sickle Cell Disease
Letter March 22 2024
Endothelial ZIP8 plays a minor role in BMP6 regulation by iron in mice
Research Article March 21 2024
Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms
Research Article March 21 2024
Genetic regulation of carnitine metabolism controls lipid damage repair and aging RBC hemolysis in vivo and in vitro
Research Article March 21 2024
Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043 patient/years analysis
Research Article March 19 2024
Peak ADAMTS13 activity to assess ADAMTS13 conformation and risk of relapse in immune-mediated Thrombotic Thrombocytopenic Purpura
Research Article March 18 2024
Malignant progression of pre-leukemic disorders
Research Article March 18 2024
The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1b-mediated AML progression.
Research Article March 18 2024
A lineage-specific STAT5BN642H mouse model to study NK-cell leukemia
Research Article March 18 2024
Thrombosis Risk in Double Heterozygous Carriers of Factor V Leiden and Prothrombin G20210A in FinnGen and the UK Biobank
Research Article March 18 2024
Evidence for antigen presentation by human neutrophils
Review Article March 18 2024
Frontline Treatment of Mantle Cell Lymphoma
Research Article March 17 2024
Loss of Dnmt3a increased self-renewal and resistance to pegIFNα in JAK2-V617F-positive myeloproliferative neoplasms
Research Article March 17 2024
Integration of ζ-deficient CARs into the CD3-zeta gene conveys potent cytotoxicity in T and NK cells
Research Article March 17 2024
An International Learning Collaborative Phase 2 Trial for Haploidentical Bone Marrow Transplant in Sickle Cell Disease
Review Article March 17 2024
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee
Retraction March 17 2024
2023 Annual Meeting Abstract 178791 retraction
Letter March 14 2024
Second Primary Malignancies After Commercial CAR T Cell Therapy: Analysis of FDA Adverse Events Reporting System (FAERS)
Letter March 14 2024
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma
Brief Report March 8 2024
MRD at the End of Induction and EFS in T-cell Lymphoblastic Lymphoma: Children's Oncology Group Trial AALL1231
Research Article March 8 2024
Epigenetic control over cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia
Research Article March 8 2024
Mutations causing premature termination codons discriminate and generate cellular and clinical variability in HHT
Research Article March 8 2024
T cell help in the tumor microenvironment enhances rituximab-mediated NK cell ADCC
Research Article March 8 2024
DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies
Research Article March 8 2024
In vivo ablation of NFκB cascade effectors alleviates disease burden in myeloproliferative neoplasms
Letter March 8 2024
IDH Mutant Myeloid Neoplasms are Associated with Seronegative Rheumatoid Arthritis and Innate Immune Activation
Page 1 of 3
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement